AN2 Therapeutics, Inc. Common Stock
ANTX
ANTX: AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.
moreShow ANTX Financials
Recent trades of ANTX by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ANTX's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ANTX's company Twitter account
Number of mentions of ANTX in WallStreetBets Daily Discussion
Recent insights relating to ANTX
Recent picks made for ANTX stock on CNBC
ETFs with the largest estimated holdings in ANTX
Flights by private jets registered to ANTX